All-in-one foam sacrum dressing
Mepilex Border Sacrum
Five-layer foam dressing for pressure ulcer prevention and management of sacral wounds
Mepilex® Border Sacrum all-in-one dressing is the only five-layer foam sacral dressing with proprietary Deep Defense Technology® – proven to prevent pressure injuries when used in conjunction with other standard prevention protocols 1 2 3 4 5 6 .
The design also creates an optimal healing environment for managing moderate- to high-exuding wounds of the sacral area. It effectively absorbs and retains exudate 7 8 and it balances moisture properly avoiding the risk of maceration 9 10 .
This recently-launched enhanced design includes new handling tabs and thicker borders allowing easier application and patient checking. When used for pressure injury prevention, the sacral shape has been refined so you can achieve good coverage of the high-risk sacral area – and it features an improved gluteal seal for maximum protection.
The enhanced design still includes Safetac® – the original less-pain contact layer with silicone adhesion. So the dressing moulds softly to skin without sticking to the moist wound 4 11 – you can remove it easily without damaging the skin 5 . That means less pain for your patients 12 .
- Proven to prevent pressure injuries – by up to 88% – when used with other standard prevention protocols 1 2 3
- Proprietary Deep Defense Technology protects against the extrinsic forces - pressure, shear and friction; and manages micro-climate, the key factors responsible for pressure injuries 4 5
Mepilex® Border with Safetac technology minimises pain during dressing changes 11
- Excellent fluid-handling capacity and retention
- Reduces risk of maceration 9
Further product information
When to use Mepilex Border Sacrum
Treatment
Use Mepilex Border Sacrum for medium-to-high exuding sacral wounds, such as pressure injuries or surgical excision of pilonidal cysts. The dressing maintains a moist wound environment, which supports debridement, so you might see an initial increase in the wound size. This is normal and to be expected.
Pressure injury prevention
A recent randomised controlled trial in the USA revealed a statistically significant effect of Mepilex Border Sacrum in reducing the incidence of hospital acquired pressure injuries – by 88% 3 You can apply the dressing prophylactically for at risk patients 2, such as the immobile, those with poor skin perfusion and impaired skin condition, in emergency rooms, in intensive care, or before and during long surgical interventions. Scientific studies have demonstrated that Mepilex Border Sacrum has the ability to impact on four extrinsic factors that can contribute to developing pressure injuries: by minimising and redistributing shear, redistributing pressure, reducing friction, and maintaining an optimal microclimate 1.
Note: the use of dressings as part of a prophylactic therapy does not preclude the need to continue to develop and follow a comprehensive pressure injury prevention protocol.
How to use Mepilex Border Sacrum
Step-by-step instructions - initial application
Assess the patient’s anatomy and determine appropriate dressing positioning.
After skin is prepared, remove the center release film by gently pulling on pink-lined edge.
Hold buttocks apart. Apply dressing to sacral area and into upper aspect of gluteal cleft, with dressing ‘base’ positioned to cover coccyx area.
Remove side release films and gently smooth each side into place.
Product placement.
Press and smooth the dressing to ensure the entire dressing is in contact with the skin.Step-by-step instructions - reapplication
Assess to confirm dressing is intact and applied correctly.
Gently pull handling tabs to begin to release dressing from skin.
Continue to release dressing from skin using handling tabs until skin exposed for skin check.
While maintaining dressing position at gluteal cleft, perform assessment of skin.
Reapply the foam and borders of the dressing.
Confirm dressing is replaced to its original position, making sure the border is intact and flat.
Press and smooth the dressing to ensure the entire dressing is in contact with the skin.How Mepilex Border Sacrum with Deep DefenseTM Technology helps in pressure injury prevention
Mölnlycke related products
'References'
- Santamaria N, et al. A randomized controlled trial of the effectiveness of soft silicone foam multi-layer dressings in the prevention of sacral and heel pressure ulcers in trauma and critically ill patients: the border trial. Int Wound J 2013. http://dx.doi.org/10.1111/iwj.12101.
- Kalowes P, et al. Five-layered soft silicone foam dressing to prevent pressure ulcers in the intensive care unit. Am J Crit Care. 2016;25(6):e108-e119.
- Tayyib N, et al. Effectiveness of pressure ulcer prevention strategies for adult patients in intensive care units: a systematic review. Worldviews Evid Based Nurs 2016;13(6):432-444.
- Call E, et al. Enhancing pressure ulcer prevention using wound dressings: what are the modes of action? Int Wound J. 2015 [cited 14 Sep 2017];12(4):408-413. URL: doi:10.1111/iwj.12123.
- Call E, et al. Microclimate impact of prophylactic dressings using in vitro body analogue method. Wounds. 2013;25(4):94-103.
- World Union of Wound Healing Societies (WUWHS). Consensus Document: Role of dressings in pressure ulcer prevention. London, UK: Wounds Int; 2016.
- Feili F. A laboratory evaluation of the fluid management capacities of absorbent foam dressings. Poster presentation at EWMA conference, Vienna, Austria, 23-25 May 2012.
- Feili F, et al. Retention capacity. Poster presentation at EWMA Conference, Lisbon, Portugal, 14-16 May 2008.
- White R. Evidence for atraumatic soft silicone wound dressing use. Wounds UK. 2005;1(3):104-109.
- Wiberg AB, et al. Preventing maceration with a soft silicone dressing: in-vitro evaluations. Poster presented at the 3rd Congress of WUWHS, Toronto, Canada. 4-8 June 2008.
- White R. A multinational survey of the assessment of pain when removing dressings. Wounds UK. 4 (1). 2008.
- SMTL external lab reports: 10/3299/1, 3F016961, 16/5164/2, 15/4934/1, FX214298 and 16/5209/1.
